An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...

Research from the College of Medicine provides promising insights into delaying the progression of Alzheimer’s disease for ...

Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling hope it could one day work in humans.

ALK will also pay up to $320m in milestone payments to ARS in the deal, which sees the latter keep rights in the US, ...

TurboFil's fully automated UDS Vial Filling & Assembly System produces up to 100 unidose nasal spray devices per minute and ...

Once the nasal spray is absorbed through the membranes in the nose, it enters the bloodstream and works to stimulate melanin ...

Flying with a cold can leave you feeling plugged up and uncomfortable. Fortunately, some effective ways exist to relieve this ...

Michelle Peters Wellington announced Thursday that she has joined Vistagen Therapeutics as VP of communications. MM+M’s third ...

Commercial launch of neffy®(epinephrine nasal spray) underway in the United StatesSupplemental NDA for neffy®1mg dose granted priority review by ...

In an exclusive interview, the singer discusses his new leading role in 'Cabaret,' the 'American Idol' Season 8 group chat ...

Common decongestants may soon be pulled from shelves. The Food and Drug Administration (FDA) announced Wednesday its proposal ...

ALK and ARS Pharmaceuticals sign a deal giving ALK global rights to Neffy nasal spray outside key regions, targeting peak ...